Clavis Pharma ASA: Information from the Election Committee

          Clavis Pharma ASA: Information from the Election Committee

Oslo, Norway, 4 October 2013

Clavis Pharma ASA (OSE: CLAVIS), reference is made to the announcement on 17
September 2013 regarding Clavis Pharma's Extraordinary General Meeting to be
held on 8 October, and agenda item 7: Election of Board. Please find attached
additional information from the Election Committee in regards to this agenda


Gunnar Manum
Acting CEO and CFO
+47 95 17 91 90 (mob)

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Clavis Pharma recommendation by the Election Committee


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.